13MAY

VCT tax relief cut to 20% for first time

3 min read

20:05UTC

The first reduction in VCT income tax relief since the scheme's creation in 1995 took effect on 6 April. The government says investors will migrate to EIS; the assumption is untested.

← Back to State capital lands on UK tech in nine days Jump to analysis ↓

TechnologyDeveloping

Key takeaway

The first VCT relief cut in 31 years reduces institutional early-stage capital with no proven replacement.

HM Treasury cut VCT income tax relief from 30% to 20% on 6 April 2026, the first reduction since Venture Capital Trusts were created in 1995 ¹. Simultaneously, the Enterprise Investment Scheme (EIS) lifetime company limit was doubled to £24m, and the annual company investment cap rose to £10m. The government projects the combined package unlocks approximately £100m of additional investment per year.

VCTs are the primary institutional vehicle for pooled early-stage investment. Angels use EIS (which retains 30% relief), but VCTs channel capital from retail investors into portfolios of small companies. The government argues investors will migrate from VCTs to EIS. That may hold for individual angel-backed rounds, but VCTs raised approximately £1bn in 2024-25. A 10 percentage point relief cut implies a contraction in new VCT fundraising that structurally smaller EIS angel rounds cannot fully offset.

The timing compounds the effect. Beauhurst data shows UK grant awards at their lowest count since 2016. VCT-funded early stages are the hardest to replace with alternative capital. For a pre-seed spinout needing £80,000 to prove a concept, the pipeline of institutional early-stage money just narrowed at the same moment the government is deploying billions at growth stage.

Deep Analysis

In plain English

A Venture Capital Trust (VCT) is a type of investment fund that pools money from ordinary savers and invests it in small, early-stage British companies. To encourage people to invest, the government gave a 30% tax break: invest £10,000, get £3,000 back from HMRC. From April 2026, that tax break dropped to 20%. This matters because VCTs are one of the main ways small British companies raise their first significant investment. If fewer people put money into VCTs (because the tax incentive is less attractive), fewer small companies can raise the early funding they need to get started. The government argues investors will switch to a similar scheme called EIS (Enterprise Investment Scheme), which still offers 30% relief. Critics say EIS and VCTs serve different functions and one cannot simply replace the other.

Deep Analysis

Root Causes

The VCT relief cut reflects a Treasury decision that the 30% rate, introduced in 1995 at a time when venture capital was a niche activity, now over-subsidises an asset class that has matured sufficiently to compete for retail capital on its own merits.

The structural tension is that VCTs serve a dual function: they provide early-stage company finance (a market-failure correction) and tax-efficient retirement savings vehicles for higher-rate taxpayers (a general saving incentive). The Treasury's cut implicitly judges that the savings function has become dominant and the investment subsidy rate should reflect that.

A secondary cause is Whitehall coordination failure. The VCT cut (Treasury decision) was made independently of the Innovate UK restructuring (DSIT decision) and the Sovereign AI Unit launch (also DSIT). No single department owns the seed-to-Series-A funding pipeline, so Treasury optimises for fiscal efficiency while DSIT deploys growth capital, and the two policies pull in opposite directions at different stages of the same companies.

What could happen next?

Consequence
VCT fundraising may fall 25-35% in 2026-27 tax year, reducing seed-stage capital supply by £250-330m annually if the 2004 precedent holds.
Short term · 0.65
Risk
The combination of lower VCT fundraising and declining grant counts creates a structural gap in £250k-£2m funding at exactly the stage where most UK university spinouts need capital.
Medium term · 0.7
Opportunity
The EIS lifetime limit increase to £24m enables more capital per company from high-net-worth angels, which may partially compensate for VCT contraction in well-networked London-based startups.
Short term · 0.6

Source Landscape

This story draws on neutral-leaning sources

Primary parallel: In 2004, VCT income tax relief was cut from 40% to 30% following abuse of the scheme by property and entertainment investments. Total VCT fundraising fell from £503m in 2004-05 to £337m in 2005-06, a 33% decline. The HMRC data shows the market took three years to return to pre-cut levels, recovering fully only in 2008-09. The structural parallel is exact: same mechanism, same debate about EIS substitutability, same Treasury claim that the cut would be offset.

Counter-parallel: When the government tightened EIS rules in 2018 to exclude asset-backed and low-risk investments (the "patient capital" reforms), EIS investment contracted sharply by 28% in the first year but recovered within two years as the investor base refocused on genuine growth companies. This suggests VCT investors may similarly adapt, but the recovery timeline is 2-3 years, during which seed-stage capital contracts.

Immediate: VCTs raised approximately £1bn in 2024-25. A 33% contraction (consistent with the 2004 precedent) would reduce annual VCT fundraising by £330m. EIS investment totalled approximately £2.1bn in 2022-23 (HMRC data); whether the doubling of the EIS lifetime limit generates sufficient additional angel appetite to offset £330m is untested.

Structural: VCTs invest in portfolios of 20-50 companies per fund; the average VCT portfolio company receives £500k-£2m, precisely the seed-to-Series-A range where the grant count decline is also squeezing supply. The structural gap is concentrated in companies seeking £250k to £2m in risk capital with insufficient revenue for BBB direct investment and insufficient scale for institutional VC.

Consensus view: The British Private Equity and Venture Capital Association (BVCA) assessed before the change that a reduction from 30% to 20% relief would reduce annual VCT fundraising by approximately £150-200m, based on modelling against the 2004 reduction from 40% to 30% relief which cut VCT issuance by roughly 35% in the following tax year.

The Institute for Fiscal Studies (IFS) broadly agrees that relief elasticity in the VCT market is high because retail investors have alternative tax-efficient vehicles (ISAs, EIS, SIPPs).

Counter-view: HM Treasury's own modelling projects the EIS expansion (doubled £24m lifetime limit, raised annual limit to £10m) will absorb the reduction in VCT capital because angel investors will deploy larger individual cheques per company. The Treasury's £100m additional annual investment projection implies they expect a net positive. Octopus Ventures, the UK's largest VCT manager, has publicly stated it expects fundraising volumes to hold.

Key tension: Whether institutional VCT capital (pooled retail, deployed by fund managers across 20-50 portfolio companies) is genuinely substitutable by angel EIS capital (individual investors, typically 3-10 companies per investor), given that VCTs fund portfolio construction at a scale no single angel can replicate.

Sources:HM Treasury / HMRC·HM Treasury / HMRC

Mentions:US Treasury →HMRC →Venture Capital Trusts →Enterprise Investment Scheme →Prima →Institute for Fiscal Studies →Beauhurst →

First Reported In

Update #1 · State capital floods in, seed money drains

HM Treasury / HMRC· 13 Apr 2026

Read original →

Causes and effects

This Event

VCT tax relief cut to 20% for first time

The cut weakens the primary institutional channel for pooled retail investment into early-stage UK companies.

Led to

VCTs hit £917.7m record, brace for 65% fall

The VCT fundraising record of £917.7m was a deadline rush directly caused by the November 2025 Budget announcement of the VCT relief cut (ID:2342), effective 6 April 2026.

Occurred 13 Apr 2026

Read story →

Ineffable lands $1.1bn seed, SAIU rides minority

VCT tax relief cut to 20% removed the retail seed pool; absence of VCT-backed angels from all rounds including Ineffable confirms the post-cut investor map.

Occurred 27 Apr 2026

Read story →

Paymentology raises $175m for card issuance expansion

The April 2026 VCT relief cut (ID:2342) creates seed-stage funding pressure, making the Paymentology $175m Series-stage raise representative of the resilience above seed that public capital does not reach.

Occurred 12 May 2026

Read story →

Different Perspectives

Australian Department of Defence (AUKUS AI for Acoustics partner)

Rowden Technologies holds active AUKUS AI for Acoustics contracts with the UK, US, and Australian defence establishments. The NWF's £25m investment in Rowden on 13 May brings UK sovereign capital directly into a trilateral programme, which from Canberra's perspective places additional UK government skin-in-the-game on a programme Australia co-funds and co-develops.

Sofinnova Partners (European VC co-investor in Cytospire Series A)

Sofinnova participated alongside the BBB in Cytospire's oversubscribed £61m Series A on 5 May, demonstrating that the BBB's expanded direct mandate is attracting established European specialist biotech funds rather than replacing them. European VCs see the BBB's cornerstone position as a signal reducing UK biotech execution risk rather than crowding out private capital.

Temasek (Singapore sovereign co-investor in Isomorphic Series B)

Singapore's Temasek co-invested alongside the UK's SAIU in Isomorphic's $2.1bn round, treating the same Alphabet-majority company as an acceptable sovereign co-investment target. Temasek's participation normalises the structure: multiple sovereign wealth funds backed the same round, strengthening the precedent that UK-headquartered Alphabet subsidiaries qualify for state investment.

Alphabet / Google (majority Isomorphic shareholder, Mountain View)

Alphabet co-invested via GV and CapitalG in the same Isomorphic Series B round that received UK sovereign backing, placing US corporate capital and UK public capital in the same syndicate without any governance asymmetry. SAIU's minority stake validates Isomorphic's strategic value without constraining Alphabet's control over IP, geography, or exit decisions.

DSIT / Liz Kendall, Secretary of State for Science

DSIT framed the Isomorphic investment as backing a British-founded and headquartered company advancing UK AI capability, and described the nine-day sovereign deployment sprint as evidence the government's industrial strategy is operational. The department has not addressed the ownership question, the absence of eligibility criteria, or the pace-versus-doctrine tension in the BBB mandate.

Beauhurst / UK startup data analysts

Five sub-£50m rounds closed in nine days with zero VCT-backed angel networks on any cap table, confirming the post-cut investor map is forming fast in the £4m–£40m band. The gap is structural: 36.7% of university spinouts raised below £500,000 in 2025, a tier neither the SAIU nor the BBB direct mandate touches.